2026-07-13 Ilya Pharma presenting at Gordon Research Conference - Engineered Microbes for Treatment of Disease, Lewiston Aug 2-7 2026
2026-05-24 Shareholders are invited to Annual General Meeting June 15 at 12-13, Uppsala Business Park
2026-02-03 US Congress passes bill that reauthorises the FDA’s paediatric priority voucher pathway for five more years
2025-12-05 The research program ILP101 Inhale receives funding for in vivo proof-of-concept testing from The Swedish Cystic Fibrosis Association
2025-09-22 Ilya Pharma selected to present at 27th Annual SoCalBio Investor and Partnering Conference October 1-2 in Newport Beach
2025-07-17 Ilya Pharma recieves decision to grant from European Patent Office for its second patent covering the ILP-drug candidates and their use in skin and mucosa in humans and animals
2024-11-27 Ilya Pharma participates at SIN UK-Northern Europe Panel on "Galvanising AMR Financing" Nov 27, British Ambassadors Residence
